Non-Invasive Evaluation of Non-Alcoholic Steatohepatitis (NASH) and...

This expert-led webinar will review the most promising biomarkers for NASH fibrosis including their performance, advantages and limitations in both clinical development and in daily clinical practice.(PRWeb February 26, 2020)Read the full story at https://www.prweb.com/releases/non_invasive_evaluation_of_non_alcoholic_steatohepatitis_nash_and_advanced_fibrosis_present_and_future_upcoming_webinar_hosted_by_xtalks/prweb16936077.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news